Phase III PsA Primary Study
Research payments
$126,536
Through program year 2020, $126,536 in research payments was reported against Phase III PsA Primary Study, across 13 payments, paid by E.R. Squibb & Sons, L.L.C..
- Paid by
- E.R. Squibb & Sons, L.L.C.
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
2 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2020 | Research | $23,532 | 2 |
| 2019 | Research | $103,003 | 11 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
9 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Gary Craig Spokane, WA Named on 2 payments
- Isam Diab Cleveland, OH Named on 1 payment
- Christine Codding Oklahoma City, OK Named on 1 payment
- Mary Howell Hagerstown, MD Named on 1 payment
- Robert Griffin Wyomissing, PA Named on 1 payment
- John Tesser Phoenix, AZ Named on 1 payment
- Charles Ludivico Bethlehem, PA Named on 1 payment
- Jeffrey Kaine Sarasota, FL Named on 1 payment
- Jay Warrrick Knoxville, TN Named on 1 payment
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.